ASPIRE BIOPHARMA HOLDINGS, INC. (ASBPW) Net income 2022–2025
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBPW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$24.5MFY2025 · since FY2022: $3.3M → -$24.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.5M | -1768.9% |
| FY2024 | -$1.3M | -129.3% |
| FY2023 | $4.5M | +33.6% |
| FY2022 | $3.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ASBPW financial trends
ASBPW RevenueASBPW Net marginASBPW Gross profitASBPW Gross marginASBPW Operating incomeASBPW Operating marginASBPW Operating cash flowASBPW Free cash flowASBPW Capital expendituresASBPW Return on equityASBPW Stock buybacksASBPW Dividends paidASBPW Total assetsASBPW Total liabilitiesASBPW Shareholders’ equityASBPW overview →